Similar articles

• Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.

  Roseborough I, Lee H, Chwalek J, Stamper RL, Price VH. Roseborough I, et al. J Am Acad Dermatol. 2009 Apr;60(4):705-6. doi: 10.1016/j.jaad.2008.08.029. J Am Acad Dermatol. 2009. PMID: 19293023 Clinical Trial. No abstract available.
• Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth.

  Yoelin S, Walt JG, Earl M. Yoelin S, et al. Dermatol Surg. 2010 May;36(5):638-49. doi: 10.1111/j.1524-4725.2010.01519.x. Epub 2010 Apr 1. Dermatol Surg. 2010. PMID: 20384751 Clinical Trial.
• Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata.

  Ochoa BE, Sah D, Wang G, Stamper R, Price VH. Ochoa BE, et al. J Am Acad Dermatol. 2009 Sep;61(3):530-2. doi: 10.1016/j.jaad.2009.01.027. J Am Acad Dermatol. 2009. PMID: 19700021 Clinical Trial. No abstract available.
• Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature.

  Aydin S, Işikligil I, Tekşen YA, Kir E. Aydin S, et al. Cutan Ocul Toxicol. 2010 Sep;29(3):212-6. doi: 10.3109/15569521003796860. Cutan Ocul Toxicol. 2010. PMID: 20670089 Review.
• Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth.

  Cohen JL. Cohen JL. Dermatol Surg. 2010 Sep;36(9):1361-71. doi: 10.1111/j.1524-4725.2010.01522.x. Dermatol Surg. 2010. PMID: 20384750 Review.